調查批次:CHT2017-01 | 檢體寄出日期:2017-02-06 | 報告回收截止日期:2017-02-13 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
2.47 |
-0.39 |
-13.6 |
-1.7 |
-0.4 |
-57 |
1.19 |
-0.05 |
-4.0 |
-0.5 |
0.3 |
-17 |
RH07b | RH07 | 3 |
2 |
3 |
3.15 |
0.29 |
10.1 |
1.3 |
0.8 |
42 |
0.99 |
-0.25 |
-20.2 |
-2.5 |
-1.0 |
-84 |
RH14 | RH14 | 4 |
2 |
3 |
2.87 |
0.01 |
0.3 |
0.0 |
0.3 |
1 |
1.18 |
-0.06 |
-4.8 |
-0.6 |
0.2 |
-20 |
RH15 | RH15 | 4 |
2 |
5 |
2.32 |
-0.54 |
-18.9 |
-2.4 |
-0.6 |
-79 |
1.22 |
-0.02 |
-1.6 |
-0.2 |
0.4 |
-7 |
CL009 | CL009 | 3 |
2 |
5 |
1.97 |
-0.89 |
-31.1 |
-3.9 |
-1.2 |
-130 |
0.93 |
-0.31 |
-25.0 |
-3.1 |
-1.4 |
-104 |
CL010 | CL010 | 2 |
2 |
5 |
2.14 |
-0.72 |
-25.2 |
-3.1 |
-0.9 |
-105 |
1.13 |
-0.11 |
-8.9 |
-1.1 |
-0.1 |
-37 |
CL012 | CL012 | 9 |
2 |
3 |
3.46 |
0.60 |
21.0 |
2.6 |
1.3 |
87 |
1.16 |
-0.08 |
-6.5 |
-0.8 |
0.1 |
-27 |
CL015 | CL015 | 3 |
2 |
3 |
3.03 |
0.17 |
5.9 |
0.7 |
0.6 |
25 |
1.40 |
0.16 |
12.9 |
1.6 |
1.6 |
54 |
Median of RIA Group |
2.67 |
1.17 |
||||||||||||||
Range of RIA Group |
1.97 - 3.46 |
0.93 - 1.40 |
||||||||||||||
Robust mean of RIA Group |
2.68 ( n = 8 ) |
1.15 ( n = 8 ) |
||||||||||||||
Robust SD of RIA Group |
0.600 |
0.159 |
||||||||||||||
CV of RIA Group |
22.4% |
13.8% |
||||||||||||||
Median of European RIA Labs |
2.46 ( n = 103 ) |
1.17 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.24 - 2.84 |
1.04 - 1.42 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 4 |
4 |
9 |
2.93 |
0.07 |
2.4 |
0.3 |
0.9 |
10 |
1.42 |
0.18 |
14.5 |
1.8 |
1.4 |
61 |
RH02c | RH02 | 4 |
4 |
1 |
2.24 |
-0.62 |
-21.7 |
-2.7 |
-0.7 |
-90 |
1.05 |
-0.19 |
-15.3 |
-1.9 |
-0.3 |
-64 |
RH06 | RH06 | 5 |
4 |
9 |
3.17 |
0.31 |
10.8 |
1.4 |
1.4 |
45 |
1.38 |
0.14 |
11.3 |
1.4 |
1.2 |
47 |
RH07a | RH07 | 4 |
4 |
2 |
2.46 |
-0.40 |
-14.0 |
-1.7 |
-0.2 |
-58 |
0.98 |
-0.26 |
-21.0 |
-2.6 |
-0.7 |
-88 |
RH12 | RH12 | 5 |
4 |
2 |
2.53 |
-0.33 |
-11.5 |
-1.4 |
-0.0 |
-48 |
0.95 |
-0.29 |
-23.4 |
-2.9 |
-0.8 |
-98 |
RH19 | RH19 | 7 |
4 |
2 |
2.37 |
-0.49 |
-17.1 |
-2.1 |
-0.4 |
-71 |
0.88 |
-0.36 |
-29.0 |
-3.6 |
-1.1 |
-121 |
RH20 | RH20 | 3 |
4 |
7 |
2.48 |
-0.38 |
-13.3 |
-1.7 |
-0.1 |
-55 |
1.11 |
-0.13 |
-10.5 |
-1.3 |
-0.0 |
-44 |
CL005 | CL005 | 7 |
4 |
9 |
3.03 |
0.17 |
5.9 |
0.7 |
1.1 |
25 |
1.40 |
0.16 |
12.9 |
1.6 |
1.3 |
54 |
CL006a | CL006 | 2 |
4 |
7 |
2.15 |
-0.71 |
-24.8 |
-3.1 |
-0.9 |
-103 |
1.06 |
-0.18 |
-14.5 |
-1.8 |
-0.3 |
-61 |
CL008 | CL008 | 7 |
4 |
2 |
2.68 |
-0.18 |
-6.3 |
-0.8 |
0.3 |
-26 |
1.08 |
-0.16 |
-12.9 |
-1.6 |
-0.2 |
-54 |
CL011 | CL011 | 0 |
4 |
13 |
3.02 |
0.16 |
5.6 |
0.7 |
1.1 |
23 |
1.30 |
0.06 |
4.8 |
0.6 |
0.8 |
20 |
CL013b | CL013b | 1 |
4 |
1 |
1.96 |
-0.90 |
-31.5 |
-3.9 |
-1.3 |
-131 |
0.95 |
-0.29 |
-23.4 |
-2.9 |
-0.8 |
-98 |
CL014b | CL014 | 7 |
4 |
1 |
2.01 |
-0.85 |
-29.7 |
-3.7 |
-1.2 |
-124 |
1.01 |
-0.23 |
-18.5 |
-2.3 |
-0.5 |
-77 |
Median of CLIA Group |
2.48 |
1.06 |
||||||||||||||
Range of CLIA Group |
1.96 - 3.17 |
0.88 - 1.42 |
||||||||||||||
Robust mean of CLIA Group |
2.54 ( n = 13 ) |
1.12 ( n = 13 ) |
||||||||||||||
Robust SD of CLIA Group |
0.456 |
0.214 |
||||||||||||||
CV of CLIA Group |
18.0% |
19.1% |
||||||||||||||
Median of European CLIA Labs |
2.93 ( n = 1026 ) |
1.24 ( n = 1026 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.22 - 3.14 |
1.01 - 1.34 |
||||||||||||||
Median of All Labs |
2.48 |
1.11 |
||||||||||||||
Range of All Labs |
1.96 - 3.46 |
0.88 - 1.42 |
||||||||||||||
Robust mean of All Labs |
2.59 ( n = 21 ) |
1.13 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.492 |
0.192 |
||||||||||||||
CV of All Labs |
19.0% |
17.0%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.86 |
1.24 |
||||||||||||||
uXa |
0.016 |
0.006 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.24 - 3.14 |
1.01 - 1.34 |
||||||||||||||
Mean of All European Labs |
2.74 ( n = 1197 ) |
1.19 ( n = 1197 ) |
||||||||||||||
SD of All European Labs |
0.436 |
0.155 |
||||||||||||||
CV of All European Labs |
16.0% |
13.1% |
||||||||||||||
SD for proficiency assessment ( σp ) |
0.229 |
0.099 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL013b, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-02-15